Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ocumetics Technology Corp V.OTC

Alternate Symbol(s):  OTCFF

Ocumetics Technology Corp. is a Canada-based research and product development company. The Company specializes in adaptive lens designs. It is in the preclinical study stage of development of an intraocular lens. It is focused on developing intraocular lenses for people over 45 years of age. The Ocumetics lens, which is an expandable intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses. It is designed to allow the eye’s natural muscle activity to shift focus from distance to nearby. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lens’s suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipient’s eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.


TSXV:OTC - Post by User

Comment by AL8888on Mar 23, 2022 3:12pm
268 Views
Post# 34538802

RE:Is nobody watching this stock

RE:Is nobody watching this stockI agree, there is a ton of potential in this stock. Trials are currently underway with results expected in June. Additions to the management team and recent partnerships are very promising.  The float is tightly held by original investors and daily trading volumes are low due to the fact that the long term investors are patient and have no interest in selling at this point. It would likely be difficult to take a meaningful position without upward pressure on SP.

If trial results are favorable, people will be scrambling to buy, the price will increase dramatically and quickly but there will still be money to be made because the potential revenue of this tehnology is actually hard to phathom. 
<< Previous
Bullboard Posts
Next >>